D.E. Shaw & Co’s GoodRx Holdings GDRX Stock Holding History

D.E. Shaw & Co’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-40,000	Closed	-$268K	–	4472
2023 Q4	$268K	Hold	40,000	–	–	﹤0.01%	3783
2023 Q3	$225K	Hold	40,000	–	–	﹤0.01%	3726
2023 Q2	$221K	Hold	40,000	–	–	﹤0.01%	3712
2023 Q1	$250K	Hold	40,000	–	–	﹤0.01%	3815
2022 Q4	$186K	Hold	40,000	–	–	﹤0.01%	4264
2022 Q3	$187K	Hold	40,000	–	–	﹤0.01%	4489
2022 Q2	$237K	Hold	40,000	–	–	﹤0.01%	4470
2022 Q1	$773K	Sell	40,000 -20,000	-33%	-$459K	﹤0.01%	4107
2021 Q4	$1.96M	Sell	60,000 -30,000	-33%	-$1.21M	﹤0.01%	3378
2021 Q3	$3.69M	Buy	90,000 +50,000	+125%	+$1.81M	﹤0.01%	2413
2021 Q2	$1.44M	Buy	+40,000	New	+$1.48M	﹤0.01%	3254

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

D.E. Shaw & Co's GDRX Position: Q1 2026 in Review

D.E. Shaw & Co increased its GoodRx Holdings (GDRX) stake by 35% in Q1 2026, buying an estimated $189K and bringing the position to 312,128 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #3744.

D.E. Shaw & Co first reported a position in GDRX in Q2 2021 and has held it in 17 quarters since. The position peaked at $8.32M in Q1 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

D.E. Shaw & Co held 312,128 shares of GoodRx Holdings worth $612K as of Q1 2026.
D.E. Shaw & Co bought 80,381 GoodRx Holdings shares in Q1 2026, an estimated $189K.
GoodRx Holdings made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3744 holding.
D.E. Shaw & Co first reported a position in GoodRx Holdings in Q2 2021 and has held it in 17 quarters since.
D.E. Shaw & Co's GoodRx Holdings position peaked at $8.32M in Q1 2023.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.